Matts Johansen, CEO of Aker BioMarine ASA, has through KMMN Invest II AS, a company controlled by Mr. Johansen, today purchased 14,000 shares in Aker BioMarine ASA at an average price of NOK 35,05 per share. Following the transaction, Mr. Johansen, directly and indirectly, controls 1,094,958 shares in Aker BioMarine ASA.

Please see attached primary insider notification form pursuant to the requirements of the Market Abuse Regulation (“MAR”).

This information is subject to the disclosure requirements pursuant to MAR Article 19 and Section 5-12 of the Norwegian Securities Trading Act.